TYK Medicines

CompanyChinaFounded 2017

RORWikidata

TYK Medicines develops one asset, in phase 1 (TY-302 in breast cancer). Mostly small molecule; based in China, founded in 2017.

1
Asset
Furthest stage
Phase 1
2
Trials
0
Signals

Pipeline

1
  • TY-302

    Antineoplastic agent

    Phase 1, Small molecule, breast cancer, solid tumor

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials2
  • Similar companies6

Intelligence